Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic Neurotoxicity

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neurochemistry

• Publication date

  1994-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1471-4159.1994.62062484.xPMID 8189253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic mapping of the effects of intravenous methamphetamine administration in freely moving rats

  2005cited by this paper
• Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

  1993cited by this paper
• MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.

  1993cited by this paper
• Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid

  1993cited by this paper
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

  1992cited by this paper
• Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity.

  1991cited by this paper
• Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse Brain

  1991cited by this paper
• Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

  1991cited by this paper
• Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

  1989cited by this paper
• Long-term effects of chronic methamphetamine administration in rhesus monkeys.

  1989cited by this paper
• Orally administered MDMA causes a long-term depletion of serotonin in rat brain.

  1988cited by this paper
• The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

  1986cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers.

  1984cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.

  1980cited by this paper
• Continuous measurement of adenosine triphosphate with firefly luciferase luminescence.

  1979cited by this paper
• [4] Firefly luciferase assay for ATP production by mitochondria

  1978cited by this paper
• Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration.

  1978cited by this paper
• Metabolite studies of methamphetamine effects based upon mitochondrial respiratiory state in rat brain.

  1977cited by this paper
• Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.

  1976cited by this paper
• IN VIVO EFFECTS OF AMPHETAMINE ON METABOLITES AND METABOLIC RATE IN BRAIN

  1973cited by this paper
• The effect of amphetamine and related compounds on the concentration of adenine nucleotides, inorganic phosphate and creatine phosphate in the rat brain.

  1962cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Illicit Drugs in Surface Waters: How to Get Fish off the Addictive Hook

  2024cites this paper
• Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum

  2024cites this paper
• Interactions of VMAT2 with CDCrel-1 and Parkin in Methamphetamine Neurotoxicity

  2024cites this paper
• Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder

  2021cites this paper
• Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease

  2021cites this paper
• Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice

  2020cites this paper
• PARKIN REGULATES DRUG TAKING-BEHAVIOR IN RAT MODEL OF METHAMPHETAMINE USE DISORDER

  2020cites this paper
• Methamphetamine induces neuronal death: Evidence from rodent studies.

  2019cites this paper
• Deficiency in the ROS-sensing Nuclear Factor Erythroid 2-like 2 (Nrf2) causes altered glucose and lipid homeostasis following exercise training.

  2019cites this paper
• Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

  2019cites this paper
• Nanomedicine: A New Approach for Treatment Neuropsychiatric Diseases

  2017cites this paper
• Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target.

  2017influential citation
• The neurotoxic mechanisms of amphetamine: Step by step for striatal dopamine depletion.

  2017cites this paper
• Animal Models of Mania: Essential Tools to Better Understand Bipolar Disorder

  2017cites this paper
• Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis—A Review

  2017cites this paper
• Captopril inhibited metamphetamine - induced cardiac mitochondrial damage in hyperthermic condition via modulation of biochemical markers

  2016cites this paper
• Melatonin Attenuates Methamphetamine-Induced Neurotoxicity.

  2016cites this paper
• Nuclear factor erythroid‐derived 2‐like 2 (NFE2L2, Nrf2) mediates exercise‐induced mitochondrial biogenesis and the anti‐oxidant response in mice

  2016cites this paper
• Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits

  2015cites this paper
• Methamphetamine effects on blood-brain barrier structure and function

  2015cites this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cites this paper
• Mitochondria: key players in the neurotoxic effects of amphetamines

  2015cites this paper
• Gender differences in the effect of tobacco use on brain phosphocreatine levels in methamphetamine-dependent subjects

  2015cites this paper
• Necrosis inhibitor-5 (NecroX-5), attenuates MPTP-induced motor deficits in a zebrafish model of Parkinson’s disease

  2015cites this paper
• Neuropharmacology and toxicology of novel amphetamine-type stimulants

  2015cites this paper
• Implicación de los receptores dopaminérgicos D1 y D2 en la neurotoxicidad inducida por metanfetamina

  2014cites this paper
• Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

  2014cites this paper
• Brain and Peripheral Organ Toxicity of "Ecstasy" in Adolescent Rats in Human Relevant Doses

  2014cites this paper
• Şizofreni ve Mitokondri Disfonksiyonu Schizophrenia and Mitochondria Dysfunction

  2014cites this paper
• Neurotoxicity of Methamphetamine

  2014cites this paper
• Methamphetamine Neurotoxicity and Neuroinflammatory Processes

  2014cites this paper
• MRI assessment of brain iron content in methamphetamine users

  2014influential citation
• Luteolin Inhibits Behavioral Sensitization by Blocking Methamphetamine-Induced MAPK Pathway Activation in the Caudate Putamen in Mice

  2014cites this paper
• Investigating the effects of methamphetamine on metabolite markers and white matter in the brain

  2013cites this paper
• The Contribution of Ammonia to Methamphetamine Neurotoxicity

  2013cites this paper
• The Role of Prostaglandin H Synthase (PHS) Bioactivation and Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)-Mediated Protection in Endogenous and Methamphetamine-initiated Neurotoxicity

  2013cites this paper
• Neurodegeneration from Drugs and Aging‐Derived Free Radicals

  2013cites this paper
• Effects of maternal separation and methamphetamine exposure on protein expression in the nucleus accumbens shell and core

  2012cites this paper
• Methamphetamine causes anorexia in Drosophila melanogaster, exhausting metabolic reserves and contributing to mortality.

  2012cites this paper
• High doses of METH produce long-term consequences indicative of neurotoxicity as revealed by cognitive deficits in humans and long-term decreases in markers of dopamine (DA) and 5HT neurotransmission in humans

  2012cites this paper
• Molecular and cellular bases for the protective effects of dopamine D1 receptor antagonist, SCH23390, against methamphetamine-induced neurotoxicity in the rat brain

  2012cites this paper
• An efficient extraction method for quantitation of adenosine triphosphate in mammalian tissues and cells.

  2012cites this paper
• Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo

  2011cites this paper
• Synergism between methamphetamine and the neuropeptide substance P on the production of nitric oxide in the striatum of mice.

  2011cites this paper
• A proteomic and neurochemical analysis of the effects of early life stress on drug addiction and post abuse therapeutic interventions: an animal study

  2010cites this paper
• Impact of drugs approved for treating ADHD on the cell survival and energy metabolism: an in-vitro study in human neuronal and immune cells

  2010cites this paper
• Dopamine modifies oxygen consumption and mitochondrial membrane potential in striatal mitochondria

  2010cites this paper
• A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications.

  2009cites this paper
• Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells.

  2009cites this paper
• Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment

  2009cites this paper
• Neuroprotection against Methamphetamine Induced Neurotoxicity: Applications for Parkinson’s Disease

  2009cites this paper
• The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia

  2009cites this paper
• Methamphetamine-induced neurotoxicity: the road to Parkinson’s disease

  2009cites this paper
• Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression

  2008cites this paper
• Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain.

  2008cites this paper
• The Role of Oxidative Stress, Metabolic Compromise, and Inflammation in Neuronal Injury Produced by Amphetamine-Related Drugs of Abuse

  2008cites this paper
• Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia.

  2008cites this paper
• Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis

  2007cites this paper
• Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

  2007cites this paper
• Does Thioredoxin-1 Prevent Mitochondria- and Endoplasmic Reticulum-Mediated Neurotoxicity of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine?

  2007cites this paper
• Augmentation of methamphetamine‐induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia

  2007cites this paper
• Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction.

  2007cites this paper
• Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats

  2007cites this paper
• Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine.

  2006cites this paper
• Causes and consequences of methamphetamine and MDMA toxicity

  2006cites this paper
• Methylphenidate treatment induces oxidative stress in young rat brain.

  2006cites this paper
• Effects of L‐Carnitine Pretreatment in Methamphetamine and 3‐Nitropropionic Acid‐Induced Neurotoxicity

  2006cites this paper
• Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.

  2005cites this paper
• The Role of Mitochondrial Uncoupling in 3,4-Methylenedioxymethamphetamine-Mediated Skeletal Muscle Hyperthermia and Rhabdomyolysis

  2005cites this paper
• Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man

  2005cites this paper
• Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity

  2005cites this paper
• Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review

  2005cites this paper
• Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism

  2005cites this paper
• THE SEROTONIN RECEPTOR ANTAGONISTS NAN-190, METHIOTHEPIN, METHYSERGIDE, MIANSERIN OR ONDANSETRON PROTECT AGAINST METHAMPHETAMINE-INDUCED HYPERTHERMIA IN MICE

  2005cites this paper
• The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.

  2004cites this paper
• Reactions of the putative neurotoxin tryptamine-4,5-dione with L-cysteine and other thiols.

  2004cites this paper
• Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study.

  2004cites this paper
• Mitochondria, synaptic plasticity, and schizophrenia.

  2004cites this paper
• Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.

  2004cites this paper
• Methamphetamine exacerbates the toxic effect of kainic acid in the adult rat retina.

  2004cites this paper
• Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress.

  2003cites this paper
• The molecular mechanisms of dopamine toxicity.

  2003cites this paper
• Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats.

  2003cites this paper
• Speed kills : cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis

  2003cites this paper
• The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.

  2003cites this paper
• Bioluminometric assay of ATP in mouse brain: Determinant factors for enhanced test sensitivity

  2003influential citation
• Speed kills: cellular and molecular bases of methamphetamine‐induced nerve terminal degeneration and neuronal apoptosis

  2003cites this paper
• Role of Dopaminergic and Glutamatergic Systems of the Striatum in the Mechanisms of d-Amphetamine and Ammonia Neurotoxicity

  2003cites this paper
• Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine

  2003cites this paper
• The Nigrostriatal Dopamine System and Methamphetamine: Roles for Excitotoxicity and Environmental, Metabolic and Oxidative Stress

  2002cites this paper
• Dizocilpine Inhibits Amphetamine-Induced Formation of Nitric Oxide and Amphetamine-Induced Release of Amino Acids and Acetylcholine in the Rat Brain

  2002cites this paper
• Site-selective action

  2002cites this paper
• Metabolite Alterations in Basal Ganglia Associated with Methamphetamine-related Psychiatric Symptoms: A Proton MRS Study

  2002influential citation
• 3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brain.

  2002cites this paper
• Effects of Acute Toxic Doses of Psychostimulants on Extracellular Levels of Excitatory Amino Acids and Taurine in Rats

  2002cites this paper
• Methamphetamine Toxicity: Roles for Glutamate, Oxidative Processes, and Metabolic Stress

  2002cites this paper
• Effect of Glucoprivation on Serotonin Neurotoxicity Induced by Substituted Amphetamines

  2002cites this paper
• Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine

  2002cites this paper
• Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione.

  2002cites this paper
• Effects of sydnocarb and D-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen.

  2001cites this paper